Extended adjuvant aromatase inhibition after sequential endocrine therapy (DATA): a randomised, phase 3 trial

Author(s):
Tjan-Heijnen, V.C.G.; Hellemond, I.E.G. van; Peer, P.G.M.; Swinkels, A.C.P.; Smorenburg, C.H.; Sangen, M.J.C. van der; Kroep, J.R.; Graaf, H. de; Honkoop, A.H.; Erdkamp, F.L.G.; Berkmortel, F.W.P.J. van den; Boer, M. de; Roos, W.K. de; Linn, S.C.; Imholz, A.L.T.; Seynaeve, C.M.; Dutch Breast Canc Res Grp B
Published
2017
Publication type
Article / Letter to editor
Date issued
2017-11-30
Language
English
Is part of
The Lancet Oncology (2017), Vol. 18, no. 11, p. 1502-1511
hdl
1887/95160
doi
10.1016/S1470-2045(17)30600-9